InvestorsHub Logo
Followers 5
Posts 91
Boards Moderated 0
Alias Born 09/02/2020

Re: momoney24 post# 355568

Sunday, 09/26/2021 12:31:47 PM

Sunday, September 26, 2021 12:31:47 PM

Post# of 424170
Besides BMY's 11.5% ownership of XLRN, BMY has 75-80% of Reblozyl economics, 20% royalty of XLRN's eventual potential multi-blockbuster Sotatercept in PAH,

The potential size of PAH could atrract multiple large biopharma.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News